Joseph B. Musumeci

Senior Advisor

Back to Speakers

Mr. Musumeci brings extensive global payer access, product pricing, and launch forecasting experience to support BluePrint Orphan’s mission of rare disease business development. As an owner of the Stratis Group, he has managed pharma/biotech business development and commercialization initiatives across a wide variety of therapeutic areas in the Orphan space, as well as for many of the largest brands in the industry. He has also worked in oncology product development at Eisai Pharmaceuticals and pharma consulting at Insight Strategy Advisors and Vantage Partners. He formerly worked in M&A investment banking, and in equity investments with Harris Williams & Co. and Wells Fargo, respectively.

Mr. Musumeci holds a Bachelor of Arts in Biology with a focus on Biochemistry from Harvard University.